PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease: Cost-Effectiveness in the Dutch Population

P.F. Van Gils; H.H. Hamberg-van Reenen; E. Over; G.A. de Wit; M. van den Berg; A.J. Schuit; P.M. Engelfriet

doi:10.1016/j.jval.2011.08.813

PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease: Cost-Effectiveness in the Dutch Population

Value in Health ◽

10.1016/j.jval.2011.08.813 ◽

2011 ◽

Vol 14 (7) ◽

pp. A381

Author(s):

P.F. Van Gils ◽

H.H. Hamberg-van Reenen ◽

E. Over ◽

G.A. de Wit ◽

M. van den Berg ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Dutch Population ◽

Disease Cost ◽

Prevention Of Cardiovascular Disease

Download Full-text

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population

BMJ Open ◽

10.1136/bmjopen-2011-000363 ◽

2011 ◽

Vol 1 (2) ◽

pp. e000363-e000363 ◽

Cited By ~ 21

Author(s):

P. F. van Gils ◽

E. A. B. Over ◽

H. H. Hamberg-van Reenen ◽

G. A. de Wit ◽

M. van den Berg ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Dutch Population ◽

Disease Cost ◽

Prevention Of Cardiovascular Disease

Download Full-text

The cost-effectiveness of rosuvastatin and atorvastatin in the primary prevention of cardiovascular disease based on the discovery???belux study

European Journal of Cardiovascular Prevention & Rehabilitation ◽

10.1097/00149831-200605001-00246 ◽

2006 ◽

Vol 13 (Supplement 1) ◽

pp. S61

Author(s):

M Lamotte ◽

L Annemans ◽

MC Herregods ◽

JC Daubresse ◽

G Michel ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

The Cost ◽

Prevention Of Cardiovascular Disease

Download Full-text

PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES

Value in Health ◽

10.1016/s1098-3015(10)67445-1 ◽

2005 ◽

Vol 8 (6) ◽

pp. A98-A99

Author(s):

M Lamotte ◽

L Annemans ◽

T Evers ◽

M Kubin

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Low Dose ◽

Cost Effectiveness Analysis ◽

European Countries ◽

Dose Aspirin ◽

Effectiveness Analysis ◽

Low Dose Aspirin ◽

Prevention Of Cardiovascular Disease

Download Full-text

Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease

Value in Health ◽

10.1016/j.jval.2017.08.1223 ◽

2017 ◽

Vol 20 (9) ◽

pp. A614

Author(s):

CN Kohli-Lynch ◽

AE Moran ◽

G Thanassoulis ◽

AD Sniderman ◽

Y Zhang ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Risk Reduction ◽

Absolute Risk ◽

Absolute Risk Reduction ◽

Prevention Of Cardiovascular Disease

Download Full-text

Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: The Korean Individual-Microsimulation Model for Cardiovascular Health Interventions

Clinical Therapeutics ◽

10.1016/j.clinthera.2009.12.013 ◽

2009 ◽

Vol 31 (12) ◽

pp. 2919-2930 ◽

Cited By ~ 10

Author(s):

Hye-Young Kang ◽

Su-Kyoung Ko ◽

Danny Liew

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Markov Model ◽

Statin Therapy ◽

Cardiovascular Health ◽

Health Interventions ◽

Microsimulation Model ◽

The Cost ◽

Prevention Of Cardiovascular Disease

Download Full-text

Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis

BMC Cardiovascular Disorders ◽

10.1186/1471-2261-12-26 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 10

Author(s):

Torbjørn Wisløff ◽

Randi M Selmer ◽

Sigrun Halvorsen ◽

Atle Fretheim ◽

Ole F Norheim ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Antihypertensive Drugs ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Prevention Of Cardiovascular Disease

Download Full-text

Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk

Circulation ◽

10.1161/circulationaha.107.735340 ◽

2008 ◽

Vol 117 (22) ◽

pp. 2875-2883 ◽

Cited By ~ 69

Author(s):

Jacoba P. Greving ◽

Erik Buskens ◽

Hendrik Koffijberg ◽

Ale Algra

Keyword(s):

Cardiovascular Disease ◽

Cardiovascular Risk ◽

Cost Effectiveness ◽

Primary Prevention ◽

Prevention Of Cardiovascular Disease

Download Full-text

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

The American Journal of Medicine ◽

10.1016/s0002-9343(03)00074-3 ◽

2003 ◽

Vol 114 (6) ◽

pp. 485-494 ◽

Cited By ~ 37

Author(s):

Gavin J Blake ◽

Paul M Ridker ◽

Karen M Kuntz

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Statin Therapy ◽

C Reactive Protein ◽

Potential Cost ◽

Reactive Protein ◽

Prevention Of Cardiovascular Disease

Download Full-text

COMPARATIVE COST-EFFECTIVENESS ANALYSES OF THIAZIDE DIURETICS, BETABLOCKERS, CALCIUM CHANNEL BLOCKERS AND ANTAGONISTS OF THE RENIN ANGIOTENSIN SYSTEM FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE

Journal of Hypertension ◽

10.1097/00004872-200402001-00632 ◽

2004 ◽

Vol 22 (Suppl. 1) ◽

pp. S148

Author(s):

D Liew ◽

M Bertram ◽

S Lim ◽

J J McNeil ◽

T Vos

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Calcium Channel Blockers ◽

Renin Angiotensin System ◽

Channel Blockers ◽

Thiazide Diuretics ◽

Angiotensin System ◽

Comparative Cost ◽

Prevention Of Cardiovascular Disease

Download Full-text

Faculty Opinions recommendation of Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1157181.617296 ◽

2009 ◽

Author(s):

Alessandro Capucci ◽

Daniela Aschieri

Keyword(s):

Cardiovascular Disease ◽

Cardiovascular Risk ◽

Cost Effectiveness ◽

Primary Prevention ◽

Prevention Of Cardiovascular Disease

Download Full-text